Klépierre SA

ENXTPA:LI Stock Report

Market Cap: €8.2b

Klépierre Valuation

Is LI undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of LI when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: LI (€28.76) is trading above our estimate of fair value (€16.61)

Significantly Below Fair Value: LI is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for LI?

Key metric: As LI is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for LI. This is calculated by dividing LI's market cap by their current earnings.
What is LI's PE Ratio?
PE Ratio12.1x
Earnings€677.30m
Market Cap€8.23b

Price to Earnings Ratio vs Peers

How does LI's PE Ratio compare to its peers?

The above table shows the PE ratio for LI vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average27.5x
CARM Carmila
44.4x21.6%€2.3b
MERY Mercialys
16.8x13.5%€996.2m
FREY Frey
31.8xn/a€912.8m
SELER Selectirente
16.9xn/a€362.3m
LI Klépierre
12.1x9.4%€8.2b

Price-To-Earnings vs Peers: LI is good value based on its Price-To-Earnings Ratio (12.1x) compared to the peer average (27.5x).

Price to Earnings Ratio vs Industry

How does LI's PE Ratio compare vs other companies in the European Retail REITs Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
LI 12.1xIndustry Avg. 22.1xNo. of Companies4PE01632486480+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: LI is good value based on its Price-To-Earnings Ratio (12.1x) compared to the European Retail REITs industry average (22.1x).

Price to Earnings Ratio vs Fair Ratio

What is LI's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

LI PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio12.1x
Fair PE Ratio20.1x

Price-To-Earnings vs Fair Ratio: LI is good value based on its Price-To-Earnings Ratio (12.1x) compared to the estimated Fair Price-To-Earnings Ratio (20.1x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst LI forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€28.76
€29.73
+3.4%
10.8%€34.00€23.00n/a15
Nov ’25€29.38
€29.73
+1.2%
10.8%€34.00€23.00n/a15
Oct ’25€29.62
€28.23
-4.7%
10.9%€32.50€23.00n/a15
Sep ’25€27.06
€27.05
-0.05%
15.2%€33.70€21.00n/a15
Aug ’25€26.78
€27.05
+1.0%
15.2%€33.70€21.00n/a15
Jul ’25€25.20
€26.56
+5.4%
15.0%€33.40€21.00n/a15
Jun ’25€26.60
€24.67
-7.2%
17.2%€32.00€14.60n/a15
May ’25€25.26
€24.63
-2.5%
16.9%€32.00€14.60n/a15
Apr ’25€24.00
€24.36
+1.5%
16.7%€32.00€14.60n/a15
Mar ’25€23.48
€24.11
+2.7%
17.5%€31.80€14.60n/a15
Feb ’25€23.68
€24.01
+1.4%
17.4%€31.40€14.60n/a15
Jan ’25€24.68
€23.01
-6.8%
18.7%€30.10€14.60n/a15
Dec ’24€23.40
€22.93
-2.0%
19.2%€30.40€14.60n/a15
Nov ’24€23.24
€22.99
-1.1%
19.4%€30.40€14.60€29.3815
Oct ’24€23.23
€22.54
-3.0%
19.4%€29.20€14.60€29.6216
Sep ’24€24.37
€22.09
-9.4%
21.7%€29.20€12.30€27.0616
Aug ’24€23.95
€22.01
-8.1%
21.4%€28.40€12.30€26.7816
Jul ’24€22.72
€21.69
-4.5%
20.9%€28.40€12.30€25.2016
Jun ’24€21.29
€21.63
+1.6%
20.6%€28.00€12.30€26.6016
May ’24€22.96
€21.73
-5.3%
21.4%€28.00€12.30€25.2615
Apr ’24€20.85
€21.12
+1.3%
22.3%€28.00€12.30€24.0015
Mar ’24€23.39
€21.47
-8.2%
24.5%€31.00€12.30€23.4815
Feb ’24€23.25
€21.39
-8.0%
24.2%€31.00€12.30€23.6815
Jan ’24€21.53
€21.20
-1.5%
22.8%€31.00€12.30€24.6815
Dec ’23€21.97
€20.73
-5.7%
22.4%€31.00€12.30€23.4015
Nov ’23€20.47
€20.61
+0.7%
22.3%€31.00€12.30€23.2415

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

Healthcare Activos Yield SOCIMI

€245.6m

Operates as a real estate investment vehicle that focuses on the healthcare sector in Europe.

MLHAY

€1.41

7D

0%

1Y

4.4%

Faifey Invest Socimi

€98.7m

Invests in real estate assets in Spain.

MLECE

€19.50

7D

0%

1Y

20.4%

Paref

€60.9m

Owns and manages business real estate located primarily in the Paris region.

PAR

€40.40

7D

1.0%

1Y

-14.8%